There are a number of reasons why splitting semaglutide pens is risky
Additional indications vary between drugs, with semaglutide approved for use in 12 years and above for weight management, while tirzepatide is approved for use in 10-year-olds and above for T2DM Both medications share similar gastrointestinal side effects, which leads many patients to discontinue use, as well as boxed warnings regarding the risk of thyroid tumors
The WeightCare tirzepatide monthly program costs $499 per month, with doses ranging from 2.5mg to 15mg per week
A complete CoA for a research peptide will typically include: assigned batch number, peptide sequence and molecular weight, HPLC purity result, mass spectrometry confirmation, water content, peptide content by quantitative method, and storage and handling instructions
Perovic, D., et al